12:00 AM
 | 
Jun 24, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Prasugrel regulatory update

Daiichi Sankyo submitted an NDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for prasugrel to treat patients with ischemic heart disease undergoing percutaneous coronary...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >